1. A Bayesian adaptive design for cancer phase I trials using a flexible range of doses. Issue 3 (4th May 2018) Authors: Tighiouart, Mourad; Cook-Wiens, Galen; Rogatko, André Journal: Journal of biopharmaceutical statistics Issue: Volume 28:Issue 3(2018) Page Start: 562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials. (7th April 2016) Authors: Tighiouart, Mourad; Li, Quanlin; Rogatko, André Other Names: Cheung Ken guestEditor.; Iasonos Alexia guestEditor.; Jaki Thomas guestEditor.; O'Quigley John guestEditor. Journal: Statistics in medicine Issue: Volume 36:Number 2(2017) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations in the Presence of a Baseline Covariate. (1st November 2018) Authors: Diniz, Márcio Augusto; Kim, Sungjin; Tighiouart, Mourad Other Names: Abebe Ash Academic Editor. Journal: Journal of probability and statistics Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Bayesian seamless phase I–II trial design with two stages for cancer clinical trials with drug combinations. Issue 5 (9th March 2020) Authors: Jiménez, José L.; Kim, Sungjin; Tighiouart, Mourad Journal: Biometrical journal Issue: Volume 62:Issue 5(2020:Sep.) Page Start: 1300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A nonparametric Bayesian method for dose finding in drug combinations cancer trials. (25th January 2022) Authors: Razaee, Zahra S.; Cook‐Wiens, Galen; Tighiouart, Mourad Journal: Statistics in medicine Issue: Volume 41:Number 6(2022) Page Start: 1059 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors. Issue 4 (25th December 2019) Authors: Qayed, Muna; Cash, Thomas; Tighiouart, Mourad; MacDonald, Tobey J.; Goldsmith, Kelly C.; Tanos, Rachel; Kean, Leslie; Watkins, Benjamin; Suessmuth, Yvonne; Wetmore, Cynthia; Katzenstein, Howard M. Journal: Pediatric blood & cancer Issue: Volume 67:Issue 4(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Adaptive and Sequential Methods for Clinical Trials. (20th February 2013) Authors: Zhao, Yichuan; Chen, Zhengjia; Huang, Xuelin; Tighiouart, Mourad Journal: Journal of probability and statistics Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents. Issue 2 (28th May 2018) Authors: Jimenez, Jose L.; Tighiouart, Mourad; Gasparini, Mauro Journal: Biometrical journal Issue: Volume 61:Issue 2(2019:Mar.) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Combined high‐intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base. Issue 23 (17th August 2017) Authors: Zumsteg, Zachary S.; Luu, Michael; Yoshida, Emi J.; Kim, Sungjin; Tighiouart, Mourad; David, John M.; Shiao, Stephen L.; Mita, Alain C.; Scher, Kevin S.; Sherman, Eric J.; Lee, Nancy Y.; Ho, Allen S. Journal: Cancer Issue: Volume 123:Issue 23(2017) Page Start: 4583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Combining Cytotoxic Agents with Continuous Dose Levels in Seamless Phase I-II Clinical Trials. Issue 5 (26th October 2022) Authors: Jiménez, José L.; Tighiouart, Mourad Journal: Journal of the Royal Statistical Society Issue: Volume 71:Issue 5(2022) Page Start: 1996 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗